Literature DB >> 10758056

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.

M J Somers1, K Mavromatis, Z S Galis, D G Harrison.   

Abstract

BACKGROUND: Angiotensin II-induced hypertension is associated with increased vascular superoxide production, which contributes to hypertension caused by the octapeptide. In cell culture, stretch increases endothelial and vascular smooth muscle production of reactive oxygen species (ROS). In perfused isolated vessels, elevations of pressure can increase vessel angiotensin II production. The effects of low-renin hypertension on vascular ROS production remain unclear. Furthermore, the role of ROS in vascular function and hypertension in low-renin hypertension is undefined. METHODS AND
RESULTS: Rats were treated with DOCA and saline drinking water for 3 weeks. Both systolic blood pressure (189+/-4 versus 126+/-2 mm Hg) and aortic superoxide production (3972+/-257 versus 852+/-287, P<0. 05) were increased compared with controls. Relaxations of vascular segments to acetylcholine (ACh, 100+/-2% versus 75+/-2%, P<0.05) and the calcium ionophore A23187 (92+/-2% versus 72+/-3%, P<0.05) were also impaired in DOCA-salt. Heparin-binding superoxide dismutase (1200 U/d IV for 3 days) had no effect on blood pressure but significantly improved relaxations to ACh and A23187. Losartan (25 mg x kg(-1) x d(-1) PO) for 7 days did not correct the hypertension or endothelium-dependent vessel relaxation in DOCA-salt rats, excluding a role of a local renin/angiotensin II system.
CONCLUSIONS: These findings indicate that increased vascular superoxide production occurs not only in angiotensin II-induced hypertension but also in hypertension known to be associated with low-renin states. Increased superoxide production alters large-vessel endothelium-dependent vascular relaxation but does not modulate blood pressure in low-renin hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758056     DOI: 10.1161/01.cir.101.14.1722

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  67 in total

Review 1.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice.

Authors:  Baojian Xue; Terry G Beltz; Ralph F Johnson; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 3.  The role of aldosterone in the metabolic syndrome.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

Review 4.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.

Authors:  Ahmed A Elmarakby; Jan M Williams; John D Imig; Jennifer S Pollock; David M Pollock
Journal:  Vascul Pharmacol       Date:  2006-09-26       Impact factor: 5.773

Review 6.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

7.  Vascular dysfunction and chronic obstructive pulmonary disease: the role of redox balance.

Authors:  Stephen J Ives; Ryan A Harris; Melissa A H Witman; Anette S Fjeldstad; Ryan S Garten; John McDaniel; D Walter Wray; Russell S Richardson
Journal:  Hypertension       Date:  2013-12-09       Impact factor: 10.190

Review 8.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

9.  Extracellular signal-regulated kinase 1/2 activation, via downregulation of mitogen-activated protein kinase phosphatase 1, mediates sex differences in desoxycorticosterone acetate-salt hypertension vascular reactivity.

Authors:  Fernanda R Giachini; Jennifer C Sullivan; Victor V Lima; Fernando S Carneiro; Zuleica B Fortes; David M Pollock; Maria Helena C Carvalho; R Clinton Webb; Rita C Tostes
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

Review 10.  Cyclic stretch, reactive oxygen species, and vascular remodeling.

Authors:  Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.